Endogenous antioxidant defense induction by melon superoxide dismutase reduces cardiac hypertrophy in spontaneously hypertensive rats

References

• Alvarez MC, Caldiz C, Fantinelli JC, Garciarena CD, Console GM, Chiappe de Cengolani GE, Mosca SM. 2008. Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress? Hypertens Res 31:1465–1476
   PubMed Web of Science ®Google Scholar
• Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. 2005. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46:943–947
   PubMed Web of Science ®Google Scholar
• Carillon J, Fouret G, Feillet-Coudray C, Lacan D, Cristol JP, Rouanet JM. 2013a. Short-term assessment of toxicological aspects, oxidative and inflammatory response to dietary melon superoxide dismutase in rats. Food Chem Tox 55:323–328
   PubMed Web of Science ®Google Scholar
• Carillon J, Knabe L, Montalban A, Stevant M, Keophiphath M, Lacan D, Cristol JP, Rouanet JM. 2013c. Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity. Mol Nutr Food Res. [Epub ahead of print]. doi: 10.1002/mnfr.201300466
   PubMed Web of Science ®Google Scholar
• Carillon J, Rio DD, Teissèdre PL, Cristol JP, Lacan D, Rouanet JM. 2012. Antioxidant capacity and angiotensin I converting enzyme inhibitory activity of a melon concentrate rich in superoxide dismutase. Food Chem 135:1298–1302
   PubMed Web of Science ®Google Scholar
• Carillon J, Romain C, Bardy G, Fouret G, Feillet-Coudray C, Gaillet S, Lacan D, et al. 2013b. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation. Improvement by dietary supplementation of a melon superoxide dismutase. Free Radic Biol Med 65:254–261
   PubMed Web of Science ®Google Scholar
• Carillon J, Rouanet JM, Cristol JP, Brion R. 2013d. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action. Pharm Res 30:2718–2728
   PubMed Web of Science ®Google Scholar
• Décordé K, Agne A, Lacan D, Ramos J, Fouret G, Ventura E, Feillet-coudray C, et al. 2009. Preventive effect of a melon extract rich in superoxide scavenging activity on abdominal and liver fat and adipokine imbalance in high-fat-fed hamsters. J Agric Food Chem 57:6461–6467
   PubMed Web of Science ®Google Scholar
• Décordé K, Ventura E, Lacan D, Ramos J, Cristol JP, Rouanet JM. 2010. An SOD rich melon extract Extramel® prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis. Nutr Metabol Cardiovasc Dis 20:301–307
   PubMed Web of Science ®Google Scholar
• Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B. 2002. Simvastatin prevents angiotensin II-induced cardiac alterations and oxidative stress. Hypertension 40:142–147
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alderman MH. 1993. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 88:1444–1455
   PubMed Web of Science ®Google Scholar
• Du Y, Guo H, Lou H. 2007. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J Agric Food Chem 55:1695–1701
   PubMed Web of Science ®Google Scholar
• Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148
   PubMed Web of Science ®Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. 2000. NAD(P)H oxidase role in cardiovascular biology and disease. Circ Res 86:494–501
   PubMed Web of Science ®Google Scholar
• Gupta S, Young D, Sen S. 2005. Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats. Am J Physiol Heart Circul Physiol 289:H20–H29
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Rev Mol Cell Biol 7:589–600
   PubMed Web of Science ®Google Scholar
• Iarema N, Konovalova GG, Lankin VZ. 1992. Changes in the activity of antioxidant enzymes in patients with hypertension. Kardiologia 32:46–48
   PubMed Web of Science ®Google Scholar
• Ito H, Torii M, Suzuki T. 1995. Decrease superoxide-dismutase activity and increased superoxide anion production in cardiac-hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 17:803–816
   PubMed Web of Science ®Google Scholar
• Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. 1997. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95:588–593
   PubMed Web of Science ®Google Scholar
• Li H, Xia N, Förstermann U. 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide. 26:102–110
   PubMed Web of Science ®Google Scholar
• Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. 1992. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 107:970–975
   PubMed Web of Science ®Google Scholar
• Mate A, Miguel-Carrasco JL, Monserrat MT, Vazquez CM. 2010. Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension. J Physiol Biochem 66:127–136
   PubMed Web of Science ®Google Scholar
• Muchova J, Sustrova M, Garaiova I, Liptakova A, Blazicek P, Kvasnicka P, Pueschel S, Durackova Z. 2001. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 31:499–508
   PubMed Web of Science ®Google Scholar
• Peixoto EBMI, Pessoa BS, Biswas SK, de Faria JBL. 2009. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 29:309–318
   PubMed Web of Science ®Google Scholar
• Perluigi M, Butterfield A. 2012. Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res 2012:724904 . doi: 10.1155/2012/724904
   PubMedGoogle Scholar
• Piotrkowski B, Koch OR, De Cavanagh EM, Fraga CG. 2009. Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats. Free Radic Res 43:390–399
   PubMed Web of Science ®Google Scholar
• Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proiettoe J, Delbridgeb LMD. 2007. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 42:1119–1128
   PubMed Web of Science ®Google Scholar
• Rugale C, Cordaillat M, Mimran A, Jover B. 2005. Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension. J Renin-Angio-Aldo S 6:154–160
   PubMed Web of Science ®Google Scholar
• Seddon M, Looi YH, Shah AM. 2007. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903–907
   PubMed Web of Science ®Google Scholar
• Smith SK, Krohn RI, Mallia AK, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DK. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
   PubMed Web of Science ®Google Scholar
• Sutra T, Décordé K, Riss J, Dallas C, Cristol JP, Rouanet JM. 2007. A commercial extract of fruits and vegetables, Oxynea, acts as a powerful antiatherosclerotic supplement in an animal model by reducing cholesterolemia, oxidative stress, and NADPH oxidase expression. J Agric Food Chem 55:4258–4263
   PubMed Web of Science ®Google Scholar
• Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, Kopilas MA, et al. 2010. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 23:192–196
   PubMed Web of Science ®Google Scholar
• van Deel ED, Lu Z, Xu X, Zhu G, Hu X, Oury TD, Bache RJ, et al. 2008. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Rad Biol Med 44:1305–1313
   PubMed Web of Science ®Google Scholar
• Yamamoto E, Lai ZF, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Ito T, et al. 2006. Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens 24:2054–2069
   Web of Science ®Google Scholar
• Zhou F, Zhong W, Xue J, Gu ZL, Xie ML. 2012. Reduction of rat cardiac hypertrophy by osthol is related to regulation of cardiac oxidative stress and lipid metabolism. Lipids 47:987–994
   PubMed Web of Science ®Google Scholar
• Zhou JY, Prognon P. 2006. Raw material enzymatic activity determination: a specific case for validation and comparison of analytical methods – the example of superoxide dismutase (SOD). J Pharm Biomed Analysis 40:1143–1148
   PubMed Web of Science ®Google Scholar